bumetanide has been researched along with Pulmonary Fibrosis in 1 studies
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, R | 1 |
| Israel, HL | 1 |
| Scott, R | 1 |
| Fish, JE | 1 |
| Peters, SP | 1 |
1 other study available for bumetanide and Pulmonary Fibrosis
| Article | Year |
|---|---|
Pulmonary fibrosis in a patient treated with bumetanide: clinical improvement associated with transition from a granulocytic to lymphocytic alveolitis.
Topics: Bronchoalveolar Lavage Fluid; Bumetanide; Diuretics; Eosinophils; Female; Humans; Lymphocytes; Macro | 1990 |